Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-144,868
Closed -$4.06M 6809
2016
Q4
$4.06M Buy
144,868
+89,463
+161% +$2.51M ﹤0.01% 2570
2016
Q3
$1.52M Buy
55,405
+1,535
+3% +$42.1K ﹤0.01% 3178
2016
Q2
$1.17M Sell
53,870
-2,952
-5% -$64.3K ﹤0.01% 3377
2016
Q1
$1.27M Sell
56,822
-35,398
-38% -$791K ﹤0.01% 3242
2015
Q4
$2.55M Sell
92,220
-19,383
-17% -$536K ﹤0.01% 2810
2015
Q3
$2.88M Buy
111,603
+4,459
+4% +$115K ﹤0.01% 2734
2015
Q2
$2.65M Sell
107,144
-4,622
-4% -$115K ﹤0.01% 2880
2015
Q1
$2.82M Buy
111,766
+31,718
+40% +$799K ﹤0.01% 2796
2014
Q4
$1.88M Buy
80,048
+5,938
+8% +$139K ﹤0.01% 3054
2014
Q3
$1.69M Buy
74,110
+8,600
+13% +$196K ﹤0.01% 3097
2014
Q2
$1.6M Sell
65,510
-7,792
-11% -$190K ﹤0.01% 3155
2014
Q1
$1.54M Buy
73,302
+14,051
+24% +$296K ﹤0.01% 3169
2013
Q4
$1.41M Buy
59,251
+3,677
+7% +$87.6K ﹤0.01% 3181
2013
Q3
$1.19M Buy
55,574
+4,094
+8% +$87.6K ﹤0.01% 3250
2013
Q2
$1.02M Buy
+51,480
New +$1.02M ﹤0.01% 3259

Other funds holding QGENF

Wells Fargo's QGENF Position: Q1 2017 in Review

Wells Fargo sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 144,868 shares — an estimated $4.06M sold.

Wells Fargo first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $4.06M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Wells Fargo reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Wells Fargo sold 144,868 QIAGEN NV shares in Q1 2017, an estimated $4.06M.
  • Wells Fargo first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Wells Fargo's QIAGEN NV position peaked at $4.06M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.